1 – 50 of 375
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Vector integration and fate in the hemophilia dog liver multi-years following AAV-FVIII gene transfer
2024) In Blood(
- Contribution to journal › Article
- 2021
-
Mark
Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
-
Mark
Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules
(
- Contribution to journal › Article
- 2020
-
Mark
Lysine-specific demethylase 1A (LSD1) restricts ex vivo propagation of human HSCs and is a target of UM171
(
- Contribution to journal › Article
-
Mark
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
(
- Contribution to journal › Letter
-
Mark
Quantitative proteomics reveals specific metabolic features of Acute Myeloid Leukemia stem cells
(
- Contribution to journal › Article
-
Mark
Is the CNS-PINK the new CNS risk model in ENKTL?
(
- Contribution to journal › Article
-
Mark
A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
2020) In Blood(
- Contribution to journal › Article
- 2019
-
Mark
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
(
- Contribution to journal › Letter
-
Mark
Osteopontin mediates murine transfusion-related acute lung injury through stimulation of pulmonary neutrophil accumulation.
(
- Contribution to journal › Article
-
Mark
Transfusion-associated circulatory overload and transfusion-related acute lung injury.
(
- Contribution to journal › Scientific review
-
Mark
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
(
- Contribution to journal › Article
- 2018
-
Mark
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT
(
- Contribution to journal › Article
-
Mark
Small Molecule Screens Identify CDK8-Inhibitors As Candidate Diamond-Blackfan Anemia Drugs
(
- Contribution to journal › Published meeting abstract
-
Mark
Mouse and human HSPC immobilization in liquid culture by CD43- or CD44-antibody coating
(
- Contribution to journal › Article
- 2017
-
Mark
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10
(
- Contribution to journal › Article
-
Mark
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
(
- Contribution to journal › Article
-
Mark
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS and neurological symptoms
(
- Contribution to journal › Article
-
Mark
Near-haploid and low hypodiploid acute lymphoblastic leukemia - two distinct subtypes but consistently poor prognosis
(
- Contribution to journal › Article
- 2016
-
Mark
Gas6 fueling tumor-mediated thrombosis.
(
- Contribution to journal › Article
-
Mark
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
(
- Contribution to journal › Article
-
Mark
Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.
(
- Contribution to journal › Article
-
Mark
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
(
- Contribution to journal › Article
-
Mark
Move over Tregs, MDSCs are here
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
(
- Contribution to journal › Article
-
Mark
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
(
- Contribution to journal › Article
-
Mark
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease : a multicenter experience
(
- Contribution to journal › Article
-
Mark
Expansion and Biased Commitment of Hematopoietic Stem Cells Towards Erythroid Cells upon Acute Anemia Induction
(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.
(
- Contribution to journal › Letter
-
Mark
Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A.
(
- Contribution to journal › Letter
-
Mark
Central nervous system relapse in peripheral T-cell lymphomas: A Swedish lymphoma registry study.
(
- Contribution to journal › Article
-
Mark
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
(
- Contribution to journal › Article
-
Mark
Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: A joint study from five Nordic countries.
(
- Contribution to journal › Article
-
Mark
The first specific antiplatelet antidote.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
FVIII inhibitors: pathogenesis and avoidance.
(
- Contribution to journal › Scientific review
-
Mark
Outcome and risk factor analysis of molecular subgroups in cytogenetically normal AML treated by allogeneic transplantation.
(
- Contribution to journal › Article
-
Mark
TGF-β signaling in the control of hematopoietic stem cells.
(
- Contribution to journal › Article
-
Mark
Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2.
(
- Contribution to journal › Article
-
Mark
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
(
- Contribution to journal › Letter
-
Mark
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
(
- Contribution to journal › Article
-
Mark
A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa.
(
- Contribution to journal › Article
-
Mark
Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.
(
- Contribution to journal › Article
-
Mark
C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury
(
- Contribution to journal › Article
-
Mark
C-reactive protein boosts antibody-mediated platelet destruction
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
(
- Contribution to journal › Article
-
Mark
Robust isolation of malignant plasma cells in multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
(
- Contribution to journal › Article